Skip to content
Riskpilot
← Back to search
Sign in
Get full access
Pia Pharma Oy
OY
Active
Y-tunnus 2552356-1
Lounamäentie 35, 05200
Rajamäki
Non-specialised wholesale trade
· NACE 4690
Est. 2013 · 13 years old
1 employees
www.piapharma.fi
Share
Finland
/
Companies
/
Non-specialised wholesale trade
/
Pia Pharma Oy
Overview
Financials
People & ownership
Related companies
Loading company…
Financials
Revenue
EUR millions
0M
0M
1M
1M
1M
0M
2021
0M
2022
0M
2023
0M
2024
0M
2025
EBITDA
EUR millions
0M
-0M
-1M
-1M
-1M
0M
2021
0M
0%
2022
0M
0%
2023
0M
0%
2024
0M
0%
2025
Income statement
EUR thousands
Item
2021
2022
2023
2024
2025
Revenue
327
405
405
459
459
Staff expenses
−58
−27
−27
−59
−59
EBITDA
15
13
13
9
9
Depreciation & amort.
—
—
−0
−0
−0
EBIT
15
13
13
9
9
Net financials
−5
−4
−4
−1
−1
Profit before tax
10
9
9
8
8
Tax
5
2
2
2
2
Net profit
6
7
7
6
6
Balance sheet
EUR thousands
Item
2021
2022
2023
2024
2025
Total assets
93
81
81
90
90
Equity
22
27
27
41
41
Long-term debt
49
23
23
0
0
Short-term debt
22
31
31
49
49
Total debt
71
54
54
49
49
Financial ratios
5-year trend
EBITDA margin
1.9%
This company
15.8%
Market median
-88% vs market
2021
2025
Equity ratio
45.7%
This company
38.2%
Market median
+20% vs market
2021
2025
Return on equity
14.7%
This company
18.4%
Market median
+20% vs market
2021
2025
Net profit margin
1.3%
This company
8.1%
Market median
-84% vs market
2021
2025
Asset turnover
5.09×
This company
1.12×
Market median
+354% vs market
2021
2025
Debt / equity
1.19×
This company
0.62×
Market median
-92% vs market
2021
2025
Annual reports & filings
Annual report 2025
Filed via PRH / YTJ · Period 2025-01-01 – 2025-12-31
View
PDF
Annual report 2024
Filed via PRH / YTJ · Period 2024-01-01 – 2024-12-31
View
PDF
Annual report 2023
Filed via PRH / YTJ · Period 2023-01-01 – 2023-12-31
View
PDF
Annual report 2022
Filed via PRH / YTJ · Period 2022-01-01 – 2022-12-31
View
PDF
Annual report 2021
Filed via PRH / YTJ · Period 2021-01-01 – 2021-12-31
View
PDF
More on Pia Pharma Oy
Overview →
Headline figures, risk assessment and company summary
People & ownership →
Management, board and shareholder breakdown
Related companies →
Corporate hierarchy, parent and subsidiary network